Blue Jet Healthcare Q3 Results: Profit Rises Despite Sharp Revenue Decline

Blue Jet Healthcare reported a mixed Q3 performance, with a sharp decline in revenue and EBITDA, while net profit showed strong growth on a year-on-year basis. Q3 Financial Performance (YoY): Net Profit: ₹99 crore vs ₹40 crore, up 59.6% Revenue: ₹192.4 crore vs ₹318.3 crore, down 39.6% EBITDA: ₹47 crore vs ₹124 crore, down 62.2% EBITDA Margin: 24.3% vs 39% Summary: While net profit increased significantly, revenue and EBITDA saw sharp declines, leading to notable margin compression. The divergence suggests the presence of non-operating gains or base effects supporting profit growth. Impact Assessment: Neutral to cautious. Core operating performance weakened during the quarter, and sustainability of profit growth will depend on recovery in revenue and margins. Learning Outcome: When net profit rises despite falling revenue and EBITDA, investors should analyze non-operating income and base effects. Core operating trends provide a clearer view of business strength.